TRINETRA › Sectors › Healthcare
Park Medi World Limited (PARKHOSPS) — share price, P/E and fundamentals
Park Medi World Limited (NSE: PARKHOSPS) closed at ₹220.90 on 30 Oct 2026, against a 52-week range of ₹138.10 – ₹305.00.
In the quarter ended 30 Jun 2026 (consolidated, filed 3 Aug 2026) it reported revenue of ₹476 cr and net profit of ₹83 cr, a 17.3% net margin.
No trailing P/E is published: only 3 filed quarters available — a trailing twelve months needs 4.
From the balance sheet dated 31 Mar 2026: return on equity 16.3%, ROCE 20.1%, debt-to-equity 0.11.
Against 65 Healthcare peers on NSE: Net margin higher than 65% of 63 sector peers; PBT margin higher than 67% of 63 sector peers; ROE higher than 67% of 63 sector peers.
Key figures
| Last close | ₹220.90 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -22.5% / -5.1% / — |
| 52-week low – high | ₹138.10 – ₹305.00 |
| Market capitalisation | ₹9,541 cr |
| Quarter revenue | ₹476 cr |
| Quarter net profit | ₹83 cr |
| Net margin | 17.3% |
| Return on equity | 16.3% |
| ROCE | 20.1% |
| Debt / equity | 0.11 |
| Current ratio | 2.06 |
| Free cash flow | ₹209 cr |
| Average daily turnover (50 days) | ₹14.5 cr |
Against Healthcare peers
| Metric | PARKHOSPS | Peer median | Percentile |
|---|---|---|---|
| Net margin | 17.34 | 12.67 | 65 |
| PBT margin | 22.09 | 17.57 | 67 |
| ROE | 16.32 | 13.86 | 67 |
| ROCE | 20.12 | 16.59 | 67 |
| Debt / equity | 0.11 | 0.11 | 51 |
| Cash conversion | 1.20 | 1.25 | 47 |
Questions
What were Park Medi World Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Park Medi World Limited reported revenue of ₹476 cr and net profit of ₹83 cr (consolidated), filed with the exchange on 3 Aug 2026.
What is Park Medi World Limited's ROE?
Return on equity is 16.3% based on the balance sheet dated 31 Mar 2026.
Does Park Medi World Limited have debt?
Debt-to-equity is 0.11 on the balance sheet dated 31 Mar 2026.
What is PARKHOSPS's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, PARKHOSPS traded between ₹138.10 and ₹305.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.